CMS Open Payments · Program Year 2024
Optimotion Implants, LLC
Optimotion Implants, LLC reported $7,959,821.63 across General Payments, Research, and Ownership to 6 physicians and teaching hospitals across 10 transactions.
- $8.0M Top quartile payer
- All-tracks total
- 10 Below-median volume
- Transactions
- 6 Below-median reach
- Recipients
- −$8.8K
- General Payments vs PY2023
Optimotion Implants, LLC reported $7,959,821.63 across all CMS Open Payments tracks (General + Research + Ownership) to 6 physicians and teaching hospitals in Program Year 2024 - ranking #210 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $5,238.63, averaging $1.3M per recipient.
How Optimotion Implants, LLC's $8.0M all-tracks total breaks down
Optimotion Implants, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
32/100
Total payments
B
84/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer optimotion-implants-llc Optimotion Implants, LLC
$8.0M · #210/1,925 · 0.1% industry · PY2024
- TOT $8.0M
- RANK #210
- SHARE 0.1%
- TXN 10
- RCP 6
- CAT 2
- GEN $5.2K
- ΔGEN −$8.8K
- TOP1 57.3%
- PY 2024
Volume peers
Nearest volume peer: Applied Medical Corporation ($8.0M)
Optimotion Implants, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Optimotion Implants, LLC's CMS-reported General Payments decreased by $8.8K (−62.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: OPTIMOTION IMPLANTS, LLCPY2023: OPTIMOTION IMPLANTS, LLCPY2024: Optimotion Implants, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $14,000.00
- PY2024
- $5,238.63
What the Data Shows for Optimotion Implants, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Optimotion Implants, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $3.0K across 1 transactions, 57.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Optimotion Implants, LLC's 2-category general-payment breakdown at $3.0K, 57.3% of the reported total.
How Optimotion Implants, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $3.0K | 1 | 57.3% |
| Travel and Lodging | $2.2K | 5 | 42.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $5,238.63 (100.0%) of $5,238.63 in this company's General Payments records across 4 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Optimotion Implants, LLC
The five named recipients with the highest reported General Payments from this company
- 1
David Cheong
$3,000.00 across 1 reported transactions
- 2
Vuong Nguyen
$2,021.36 across 3 reported transactions
- 3
Amanda Rogan
$131.09 across 1 reported transactions
- 4
Marilyne Etienne
$86.18 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Optimotion Implants, LLC's spend rank (#210 of 1,925, top 11% by spend) and concentration rank (#389 of 1,838, top 21% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- ETS Wound Care LLC : $260.4K total payments, HHI 4864
- Biobeat USA Inc. : $11.6K total payments, HHI 4862
- Remington Medical, Inc. : $61.7K total payments, HHI 4851
- Darco International, Inc. : $8.5K total payments, HHI 4848
- Uromedica, Incorporated : $149.1K total payments, HHI 4832
- Ipsen Bioscience Inc. : $635.7K total payments, HHI 4780
- Optimotion Implants, LLC (this company) : $5.2K total payments, HHI 4777
- Topcon Corporation : $25.2K total payments, HHI 4774
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.) : $72.2K total payments, HHI 4762
- EMD Millipore Corporation : $47.0K total payments, HHI 4713
- SunMed Group Holdings, LLC : $60.3K total payments, HHI 4712
- Techfit Digital Surgery Inc : $1.7K total payments, HHI 4709
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Optimotion Implants, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Optimotion Implants, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Optimotion Implants, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Rhythm Pharmaceuticals, Inc.
Epizyme, Inc.
Macrogenics, Inc.
Integrity Orthopaedics, Inc.
Exeltis, USA Inc.
Put this to use
Optimotion Implants, LLC ranks #210 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Optimotion Implants, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Optimotion Implants, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.